Cellectis (CLLS) Income from Continuing Operations: 2015-2023
Historic Income from Continuing Operations for Cellectis (CLLS) over the last 9 years, with Sep 2023 value amounting to -$14.1 million.
- Cellectis' Income from Continuing Operations rose 39.55% to -$14.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$40.4 million, marking a year-over-year increase of 24.24%. This contributed to the annual value of -$80.8 million for FY2022, which is 141.85% down from last year.
- Cellectis' Income from Continuing Operations amounted to -$14.1 million in Q3 2023, which was down 555.30% from $3.1 million recorded in Q2 2023.
- Over the past 5 years, Cellectis' Income from Continuing Operations peaked at $14.4 million during Q1 2020, and registered a low of -$42.4 million during Q3 2021.
- For the 3-year period, Cellectis' Income from Continuing Operations averaged around -$16.9 million, with its median value being -$14.1 million (2023).
- Its Income from Continuing Operations has fluctuated over the past 5 years, first spiked by 162.34% in 2020, then tumbled by 183.93% in 2021.
- Over the past 5 years, Cellectis' Income from Continuing Operations (Quarterly) stood at -$38.5 million in 2019, then declined by 1.74% to -$39.2 million in 2020, then spiked by 79.39% to -$8.1 million in 2021, then slumped by 47.88% to -$11.9 million in 2022, then soared by 39.55% to -$14.1 million in 2023.
- Its Income from Continuing Operations was -$14.1 million in Q3 2023, compared to $3.1 million in Q2 2023 and -$17.5 million in Q1 2023.